Anti-inflammatory potential of stevia residue extract against uric acid-associated renal injury in mice
Abstract Tirzepatide, a dual agonist of Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide 1 (GLP-1) receptors, improved glucose control and reduced body weight in different therapeutic approaches
D Bhanu Prakash MBBS, AFIH, Advanced certificate in critical care medicine, Fellowship in critical care medicine Last updated on 13th Jan, 2026 A delayed period can be a source of significant anxiety and confusion
The TECOS trial showed no difference between the placebo and a sitagliptin group (Table 2) [47,48,49]
GLP-1 agonists primarily act in the gut-brain axis, significantly slowing gastric emptying, promoting satiety, and consequently reducing caloric intake
Administration of MCH1R antagonists have also been shown to have anxiolytic (reducing anxiety) properties